Identification of genes differentially expressed in T cells following stimulation with the chemokines CXCL12 and CXCL10

BMC Immunology

Volumn 5, Issue , 2004, Pages

  Nagel, J E ^a   Smith, Robby J ^a   Shaw, Lindy ^a   Bertak, D ^a   Dixit, V D ^a   Schaffer, E M ^a   Taub, D D ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; COMPLEMENTARY DNA; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GEMININ; GROWTH HORMONE; LIGAND; MEMBRANE PROTEIN; MESSENGER RNA; POLYPEPTIDE; REGULATOR PROTEIN; STROMAL CELL DERIVED FACTOR 1; THIOREDOXIN; ALPHA CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CXCL12 PROTEIN, HUMAN; CXCR3 PROTEIN, HUMAN; HYBRID PROTEIN; TUMOR PROTEIN;

ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DNA SEQUENCE; DOWN REGULATION; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE ISOLATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MODULATION; MOLECULAR BIOLOGY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CALCIUM SIGNALING; CHEMOTAXIS; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMAGE SUBTRACTION; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE; TRANSCRIPTION INITIATION;

BLOTTING, WESTERN; CALCIUM SIGNALING; CHEMOKINE CXCL10; CHEMOKINE CXCL12; CHEMOKINES, CXC; CHEMOTAXIS; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; JURKAT CELLS; NEOPLASM PROTEINS; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR3; RECEPTORS, CXCR4; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBTRACTION TECHNIQUE; T-LYMPHOCYTES; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION;

EID: 26444543901     PISSN: 14712172     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-5-17     Document Type: Article

References (77)

1. Baggiolini M: Chemokines in pathology and medicine. J Intern Med 2001, 250:91-104.
2. Yoshie O, Imai T, Nomiyama H: Chemokines in immunity. Adv Immunol 2001, 78:57-110.
3. Farzan M, Babcock GJ, Vasilieva N, Wright PL, Kiprilov E, Mirzabekov T, Choe H: The role of post-translational modifications of the CXCR4 amino-terminus in SDF-1α association and HIV-1 entry. J Biol Chem 2002, 277:29484-89.
4. Aiuti A, Tavian M, Cipponi A, Ficara F, Zappone E, Hoxie J, Peault B, Bordignon C: Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lymphohematopoietic progenitors. Eur J Immunol 1999, 29:1823-31.
5. Molino M, Woolkalis MJ, Prevost N, Pratico D, Barnathan ES, Taraboletti G, Haggarty BS, Hesselgesser J, Horuk R, Hoxie JA, Brass LF: CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2. Biochem Biophys Acta 2000, 1500:227-40.
6. Van der Meer P, Goldberg SH, Fung KM, Sharer LR, Gonzalez-Scarano F, Lavi E: Expression pattern of CXCR3, CXCR4, and CCR3 chemokine receptors in the developing human brain. J Neuropathol Exp Neurol 2001, 60:25-32.
7. Zhu Y, Yu T, Zhang XC, Nagasawa T, Wu JY, Rao Y: Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons. Nat Neurosci 2002, 5:719-20.
8. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR: Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-99.
9. Netelenbos T, Zuijderduijn S, van den Born J, Kessler FL, Zweegman S, Huijgens PC, Drager AM: Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells. J Leuk Biol 2002, 72:353-62.
10. Lu Q, Sun EE, Klein RS, Flanagan JG: Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell 2001, 105:69-79.
11. Nagasawa T, Tachibana K, Kawabata K: A CXC chemokine SDF-1/PBSF: a ligand for a HIV coreceptor, CXCR4. Adv Immunol 1999, 71:211-28.
12. Nagase H, Miyamasu M, Yamaguchi M, Imanishi M, Tsuno NH, Matsushima K, Yamamoto K, Morita Y, Hirai K: Cytokine-mediated regulation of CXCR4 expression in human neutrophils. J Leuk Biol 2002, 71:711-17.
13. Tudan C, Willick GE, Chahal S, Arab L, Law P, Salari H, Merzouk A: C-terminal cyclization of an SDF-1 small peptide analogue dramatically increases receptor affinity and activation of the CXCR4 receptor. J Med Chem 2002, 45:2024-31.
14. Zaitseva M, Kawamura T, Loomis R, Goldstein H, Blauvelt A, Golding H: Stromal-derived factor 1 expression in the human thymus. J Immunol 2002, 168:2609-17.
15. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-6.
16. + cells: evidence for an autocrine/paracrine mechanism. Blood 2002, 99:1117-29.
17. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T: Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-38.
18. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S, Kishimoto T, Nagasawa T: The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998, 393:591-4.
19. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B: Chemokine receptor specific for IP-10 and Mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996, 184:963-69.
20. Rappert A, Biber K, Nolte C, Lipp M, Schubel A, Lu B, Gerard NP, Gerard C, Boddeke HW, Kettenmann H: Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl-current and chemotaxis in murine microglia. J Immunol 2002, 168:3221-6.
21. Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Matsushima K, Kelvin DJ, Oppenheim JJ: Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993, 177:1809-14.
22. Taub DD, Sayers TJ, Carter CR, Ortaldo JR: Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995, 155:3877-88.
23. Loetscher P: The ligands of CXC chemokine receptor 3, ITAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem 2001, 276:2986-91.
24. Boorsma DM, Flier J, Sampat S, Ottevanger C, de Haan P, Hooft L, Willemze R, Tensen CP, Stoof TJ: Chemokine IP-10 expression in cultured human keratinocytes. Arch Dermatol Res 1998, 290:335-41.
25. Giustizieri ML, Mascia F, Frezzolini A, De Pita O, Chinni LM, Giannetti A, Girolomoni G, Pastore S: Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allerg Clin Immunol 2001, 107:871-7.
26. Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G: Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 1995, 182:155-62.
27. Zhang R, Zhang H, Zhu W, Pardee AB, Coffey RJ Jr, Liang P: Mob-1, a Ras target gene, is overexpressed in colorectal cancer. Oncogene 1997, 14:1607-10.
28. Tang P, Cheng TP, Agnello D, Wu CY, Hissong BD, Watford WT, Ahn HJ, Galon J, Moss J, Vaughan M, O'Shea JJ, Gadina M: Cybr, a cytokine-inducible protein that binds cytohesin-1 and regulates its activity. Proc Natl Acad Sci USA 2002, 99:2625-29.
29. Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF: Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappa B activation by TNF-alpha is obligatory. Diabetes 2002, 51:1319-36.
30. Suzuki Y, Rahman M, Mitsuya H: Diverse transcriptional response of CD4+ T cells to stromal cell-derived factor (SDF)-1: Cell survival promotion and priming effects of SDF-1 on CD4+T cells. J Immunol 2001, 167:3064-73.
31. Kelley TJ, Elmer HL, Corey DA: Reduced Smad3 protein expression and altered transforming growth factor-beta1-mediated signaling in cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol 2001, 25:732-38.
32. Wandinger KP, Sturzebecher CS, Bielekova B, Detore G, Rosenwald A, Staudt LM, McFarland HF, Martin R: Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann Neurol 2001, 50:349-57.
33. Sato M, Chamoto K, Tsuji T, Iwakura Y, Togashi Y, Koda T, Nishimura T: Th1 cytokine-conditioned bone marrow-derived dendritic cells can bypass the requirement for Th functions during the generation of CD8+ CTL. J Immunol 2001, 167:3687-91.
34. Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, Newman W, Groopman JE: The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 1998, 273:23169-175.
35. Vicente-Manzanares M, Rey M, Jones DR, Sancho D, Mellado M, Rodriguez-Frade JM, del Pozo MA, Yanez-Mo M, de Ana AM, Martinez C, Merida I, Sanchez-Madrid F: Involvement of phosphatidylinositol 3-kinase in stromal cell-derived factor-1 alpha-induced lymphocyte polarization and chemotaxis. J Immunol 1999, 163:4001-12.
36. Sotsios Y, Whittaker GC, Westwick J, Ward SG: The CXC chemokine stromal cell-derived factor activates a G(i)-Coupled phosphoinositide 3-kinase in T lymphocytes. J Immunol 1999, 163:5954-63.
37. Wang JF, Park IW, Groopman JE: Stromal cell-derived factor-ICE stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C. Blood 2000, 95:2505-13.
38. Bonacchi A, Romagnani P, Romanelli RG, Efsen E, Annunziato F, Lasagni L, Francalanci M, Serio M, Laffi G, Pinzani M, Gentilini P, Marra F: Signal transduction by the chemokine receptor CXCR3-Activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem 2001, 276:9945-54.
39. Darnell JE Jr, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-21.
40. Watanabe S, Arai K: Roles of the JAK-STAT system in signal transduction via cytokine receptors. Curr Opin Genet Dev 1996, 6:587-96.
41. Lewin AR, Reid LE, McMahon M, Stark GR, Kerr IM: Molecular analysis of a human interferon-inducible gene family. Eur J Biochem 1991, 199:417-23.
42. Ackrill AM, Reid LE, Gilbert CS, Gewert DR, Porter AC, Lewin AR, Stark GR, Kerr IM: Differential response of the human 6-16 and 9-27 genes to alpha and gamma interferons. Nucleic Acids Res 1991, 19:591-98.
43. Cowling RT, Birnboim HC: Preliminary characterization of the protein encoded by human testis-enhanced gene transcript (TEGT). Mol Membr Biol 1998, 15:177-87.
44. Xu Q, Reed JC: Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol Cell 1998, 1:337-46.
45. Jean JC, Oakes SM, Joyce-Brady M: The Bax inhibitor-1 gene is differentially regulated in adult testis and developing lung by two alternative TATA-less promoters. Genomics 1999, 57:201-8.
46. St-Jacques B, Dassule HR, Karavanova I, Botchkarev VA, Li J, Danielian PS, McMahon JA, Lewis PM, Paus R, McMahon AP: Sonic hedgehog signaling is essential for hair development. Curr Biol 1998, 8:1058-68.
47. Klein RS, Rubin JB, Gibson HD, DeHaan EN, Alvarez-Hernandez X, Segal RA, Luster AD: SDF-1 alpha induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells. Development 2001, 128:1971-81.
48. Lu M, Grove EA, Miller RJ: Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci USA 2002, 99:7090-95.
49. Suñe C, Garcia-Blanco MA: Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-boxdependent manner. Mol Cell Biol 1999, 19:4719-28.
50. de la Fuente C, Santiago F, Deng L, Eadie C, Zilberman I, Kehn K, Maddukuri A, Baylor S, Wu K, Lee CG, Pumfery A, Kashanchi F: Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals. BMC Biochem 2002, 3:14-35.
51. Goldstrohm AC, Albrecht TR, Sune C, Bedford MT, Garcia-Blanco MA: The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1. Mol Cell Biol 2001, 21:7617-28.
52. Wang KC, Cheng AL, Chuang SE, Hsu HC, Su IJ: Retinoic acid-induced apoptotic pathway in T-cell lymphoma: Identification of four groups of genes with differential biological functions. Exp Hematol 2000, 28:1441-50.
53. Holbert S, Denghien I, Kiechle T, Rosenblatt A, Wellington C, Hayden MR, Margolis RL, Ross CA, Dausset J, Ferrante RJ, Neri C: The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc Natl Acad Sci USA 2001, 98:1811-16.
54. McGarry TJ, Kirschner MW: Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 1998, 93:1043-53.
55. Lygerou Z, Nurse P: License withheld-geminin blocks DNA replication. Science 2000, 290:2271-73.
56. Madine M, Laskey R: Geminin bans replication licence. Nat Cell Biol 2001, 3:E49-50.
57. Hodgson B, Li A, Tada S, Blow JJ: Geminin becomes activated as an inhibitor of Cdt1/RLF-B following nuclear import. Curr Biol 2002, 12:678-83.
58. Bickel PE, Scherer PE, Schnitzer JE, Oh P, Lisanti MP, Lodish HF: Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J Biol Chem 1997, 272:13793-802.
59. Couet J, Belanger MM, Roussel E, Drolet MC: Cell biology of caveolae and caveolin. Adv Drug Deliv Rev 2001, 49:223-35.
60. Volonte D, Galbiati F, Li S, Nishiyama K, Okamoto T, Lisanti MP: Flotillins- cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe. J Biol Chem 1999, 274:12702-709.
61. Nguyen DH, Taub DD: Cholesterol is essential for macrophage inflammatory protein 1 beta binding and conformational integrity of CC chemokine receptor 5. Blood 2002, 99:4298-306.
62. Nguyen DH, Taub DD: CXCR4 function requires membrane cholesterol: implications for HIV infection. J Immunol 2002, 168:4121-126.
63. Salzer U, Prohaska R: Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts. Blood 2001, 97:1141-143.
64. Powis G, Montfort WR: Properties and biological activities of thioredoxins. Annu Rev Pharmacol Toxicol 2001, 41:261-95.
65. Toone WM, Morgan BA, Jones N: Redox control of AP-1-like factors in yeast and beyond. Oncogene 2001, 20:2336-346.
66. Okamoto T, Asamitsu K, Tetsuka T: Thioredoxin and mechanism of inflammatory response. Methods Enzymol 2002, 347:349-60.
67. Nishinaka Y, Nakamura H, Yodoi J: Thioredoxin cytokine action. Methods Enzymol 2002, 347:332-38.
68. Nordberg J, Arner ES: Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001, 31:1287-1312.
69. Tanaka T, Nakamura H, Nishiyama A, Hosoi F, Masutani H, Wada H, Yodoi J: Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging. Free Radic Res 2001, 33:851-55.
70. Torti FM, Torti SV: Regulation of ferritin genes and protein. Blood 2002, 99:3505-16.
71. Torti SV, Kwak EL, Miller SC, Miller LL, Ringold GM, Myambo KB, Young AP, Torti FM: The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem 1988, 263:12638-44.
72. Wei Y, Miller SC, Tsuji Y, Torti SV, Torti FM: Interleukin 1 induces ferritin heavy chain in human muscle cells. Biochem Biophys Res Commun 1990, 169:289-96.
73. Kwak EL, Larochelle DA, Beaumont C, Torti SV, Torti FM: Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem 1995, 270:15285-93.
74. Yokomori N, Iwasa Y, Aida K, Inoue M, Tawata M, Onaya T: Transcriptional regulation of ferritin messenger ribonucleic acid levels by insulin in cultured rat glioma cells. Endocrinology 1991, 128:1474-80.
75. Leedman PJ, Stein AR, Chin WW, Rogers JT: Thyroid hormone modulates the interaction between iron regulatory proteins and the ferritin mRNA iron-responsive element. J Biol Chem 1996, 271:12017-23.
76. Drapier JC, Hirling H, Wietzerbin J, Kaldy P, Kuhn LC: Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J 1993, 12:3643-49.
77. Cairo G, Recalcati S, Pietrangelo A, Minotti G: The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. Free Radic Biol Med 2002, 32:1237-43.